Bausch Health Companies (BHC) Revenue (2009 - 2026)

Bausch Health Companies has disclosed Revenue across 18 years of filings, most recently posting $2.5 billion for Q1 2026.

• Revenue for Q1 2026 came in at $2.5 billion, up 11.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.5 billion (up 8.22% YoY), and the FY2025 annual result was $10.3 billion, up 6.66% from the prior year.
• Revenue came in at $2.5 billion for Q1 2026 at Bausch Health Companies, down from $2.8 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $2.8 billion in Q4 2025 to a low of $1.9 billion in Q1 2022.
• The 5-year median for Revenue is $2.3 billion (2025), against an average of $2.3 billion.
• Across the five-year window, Revenue plunged 69.71% in 2022 and grew 12.15% in 2024, its largest moves.
• Bausch Health Companies' Revenue stood at $2.2 billion in 2022, then increased by 9.8% to $2.4 billion in 2023, then increased by 6.27% to $2.6 billion in 2024, then grew by 9.26% to $2.8 billion in 2025, then slipped by 9.73% to $2.5 billion in 2026.
• The last three Revenue figures came in at $2.5 billion (Q1 2026), $2.8 billion (Q4 2025), and $2.7 billion (Q3 2025), per Business Quant data.